Ignite Creation Date:
2025-12-25 @ 3:36 AM
Ignite Modification Date:
2026-01-28 @ 8:06 PM
Study NCT ID:
NCT00781105
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2008-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-27
First Submit QC Date:
None
Study First Post Date:
2008-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-20
Last Update Post Date:
2017-02-23
Last Update Post Date Type:
ACTUAL